Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.annonc.2022.06.002 | DOI Listing |
Hong Kong Med J
June 2010
State Key Laboratory in Oncology in South China, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Shatin, Hong Kong.
Objective: To identify clinical markers to predict which patients with advanced colorectal cancers are likely to benefit from cetuximab-chemotherapy.
Design: Retrospective review.
Setting: Oncology unit in a university teaching hospital in Hong Kong.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!